what are glp-1 medications made from Companion Health Pack Daily Packets GLP-1 Medications and Stigma -

PMID: 23882053

In the absence of head-to-head comparisons, indirect evidence across heterogeneous trial populations with placebo or inferior active comparators provides limited guidance for clinical decision-making

If you want the deeper science on how the two work together, see our primer on prebiotics, probiotics, and synbiotics

Current clinical consensus reflects the following: Research findings are preliminary and insufficient to guide treatment decisions No regulatory approval exists for using GLP-1s in addiction treatment Early signals do not outweigh the lack of long-term outcome data Instead, clinicians continue to recommend established, evidence-based approaches, including: Behavioral therapies tailored to substance use disorders Medication-assisted treatment when medically indicated Comprehensive psychosocial support and relapse-prevention planning Comprehensive assessment remains a cornerstone of safe and effective care

This program runs through December 31, 2027

We dont have that track record in teens or really even adults yet. Better scientific understanding is only part of the equation, though